Clinical Site

Cleveland, Ohio 44195

We've found

1 trials

at this facility

A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Cleveland, OH

Use our guide to learn which trials are right for you!